par Vander Borght, T;Laloux, P;Maes, A;Salmon, Eric;Goethals, I;Goldman, Serge ;Belgian Society for Nuclear Medicine,
Référence Acta neurologica belgica, 101, 4, page (196-209)
Publication Publié, 2001-12
Référence Acta neurologica belgica, 101, 4, page (196-209)
Publication Publié, 2001-12
Article révisé par les pairs
Résumé : | The purpose of these guidelines is to assist nuclear medicine practitioners in recommending, performing, interpreting, and reporting the results of brain perfusion SPECT studies using Tc-99m radiopharmaceuticals and brain metabolism PET studies using F-18 fluorodeoxyglucose (FDG). These guidelines have been adapted and extended from those produced by the Society of Nuclear Medicine (Juni et al., 1998) and the European Association of Nuclear Medicine by a Belgian group of experts in the field trained in neurology and/or nuclear medicine. Some indications are not universally approved (e.g. brain death), but largely supported by the literature. They have been included in these guidelines in order to provide recommendations and a standardised protocol. |